![3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide structure](/static/products/374/374085-11-7.png)
3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide
TL;DR: 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide (CAS 374085-11-7) is a chemical compound with molecular formula C22H24N4O5 and molecular weight 424.17 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[2-[(2-hydroxy-1-propylindol-3-yl)diazenyl]-2-oxoethyl]-3,4-dimethoxybenzamide
Also Known As: 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide, 3,4-dimethoxy-N-[2-oxo-2-[2-(2-oxo-1-propylindol-3-ylidene)hydrazinyl]ethyl]benzamide, (E)-3,4-dimethoxy-N-(2-oxo-2-(2-(2-oxo-1-propylindolin-3-ylidene)hydrazinyl)ethyl)benzamide, 3,4-dimethoxy-N-[2-oxo-2-[(2E)-2-(2-oxo-1-propylindol-3-ylidene)hydrazinyl]ethyl]benzamide, 3,4-dimethoxy-N-[2-oxo-2-[(2Z)-2-(2-oxo-1-propylindol-3-ylidene)hydrazinyl]ethyl]benzamide
| Molecular Formula | C22H24N4O5 |
|---|---|
| Molecular Weight | 424.17 g/mol |
| LogP | 3.8144 |
| Topological Polar Surface Area | 114.51 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Exact Mass | 424.17468 |
| Heavy Atoms | 31 |
| Complexity | 1136.3768 |
Chemical Identifiers
| CAS Number | 374085-11-7 |
|---|---|
| SMILES | CCCN1C2=CC=CC=C2C(=C1O)N=NC(=O)CNC(=O)C3=CC(=C(C=C3)OC)OC |
Product Overview
3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide (CAS 374085-11-7), with molecular formula C22H24N4O5 and molecular weight 424.17 g/mol. IUPAC: N-[2-[(2-hydroxy-1-propylindol-3-yl)diazenyl]-2-oxoethyl]-3,4-dimethoxybenzamide.
Chemical Property Profile of 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide
Property Insights of 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide
The XLogP value of 3.8144 indicates that 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 114.51 Ų falls within the moderate polarity range, balancing permeability and solubility for 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide. Following Lipinski's Rule of Five, 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide has 2 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide?
The CAS number of 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide is 374085-11-7.
What is the molecular formula of 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide?
The molecular formula of 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide is C22H24N4O5.
What is the molecular weight of 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide?
The molecular weight of 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide is 424.17 g/mol.
Where can I buy 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide?
You can request a quote for 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide?
Yes, KEHONG BIO provides custom synthesis services for 3,4-dimethoxy-N-[[(2-oxo-1-propyl-indol-3-ylidene)amino]carbamoylmethyl]benzamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.